复星医药: 上海复星医药（集团）股份有限公司2025年A股股票期权激励计划首次授予激励对象名单

Core Viewpoint - Shanghai Fosun Pharmaceutical Group Co., Ltd. has approved the initial grant list for the 2025 A-share stock option incentive plan during the seventh meeting of its tenth board of directors [1] Group 1 - The company has outlined the names and positions of the proposed incentive recipients for the stock option plan [1] - The decision was made on August 22, 2025, indicating a strategic move to motivate and retain key personnel within the organization [1]